Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Recurrent Urinary Tract Infection
Interventions
DRUG

Conjugated Estrogen Vaginal Cream

DRUG

Estradiol Ring

DRUG

Placebo

Trial Locations (2)

10016

New York University Langone Medical Center, New York

92037

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

American Urogynecologic Society

OTHER

collaborator

NYU Langone Health

OTHER

lead

University of California, San Diego

OTHER

NCT01958073 - Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women | Biotech Hunter | Biotech Hunter